Managers

BioVentures Investors closes fourth fund at $87 mln

BioVentures Investors has raised $87 million for its fourth fund. Fund IV will focus on medical tech companies.

C&B Capital seeks to raise $50 mln for third fund

C&B Capital has raised almost $18 million for its third fund, according to an SEC filing. The target is $50 million.

Navigating the cybersecurity doldrums in 2016 and beyond

The end is not coming and other musings (and photos) from PartnerConnect

Corazon Capital racks up $37 mln for second fund

Chicago-based venture firm Corazon Capital has raised $37 million for its second fund, according to an SEC filing. The target is $39.9 million.

Top Tier’s chief of secondaries, Townsend, leaves firm

Venture funding falls in Q3 as late-stage financing pulls back

Small secondaries shop PEI Funds hit by series of departures

Maple Leaf Angels launches second Ontario angel fund

Maple Leaf Angels and Maple Leaf Angels Capital Corp have launched their second angel investment fund, MLA48 Fund II. The fund will be limited to 48 limited partners and have an expanded size and scope relative to MLA48 Fund I. Terms were not released. Fund I was launched in October 2014 to finance early-stage companies in information, communications and entertainment sectors in southern Ontario. It invested in Orchard, Sharethebus, ConferenceCloud and Oneset. Founded in 2007, Maple Leaf Angels is a Toronto-based angel investment organization.

Top Q3 Canadian VC deals collect fewer dollars, despite Thalmic Labs